ARTICLE | Company News
Cel-Sci, Northeastern Ohio Universities College of Medicine deal
October 7, 1996 7:00 AM UTC
The parties agreed to identify and test peptides associated with herpes simplex virus (HSV) using CELI's heteroconjugate technology, which combines T cell binding ligands with disease associated pepti...